Navigation Links
SFC Fluidics, Inc. Receives SBIR Phase II Funding for Development of an Implantable Drug Delivery Device
Date:8/30/2017

SFC Fluidics® is very pleased to announce it has received $1.4 million in Phase II Small Business Innovation Research funding from the National Institutes of Health for the development of an implantable, wirelessly controlled, rapid dosing drug delivery system for small animal research. The min-ePump™ implantable drug delivery device will allow real-time, remote controlled delivery of drugs and therapeutics to animal models for addiction and behavior research studies. This system will allow for improved testing methods, as currently animals are required to be tethered to a pump and tested in isolation.

Key research areas that can benefit from untethered animal behavior models include substance abuse, mood disorders, schizophrenia, choice behavior, sleep behavior, stimulus response, relapse, anxiety, avoidance, PTSD, chronic stress, aggressive behavior, cognition, depression, Alzheimer’s disease, Parkinson’s disease, aging disorders, and management of chronic pain in humans. Additionally, the min-ePump™ will provide tremendous advantages for the development of a simple patch pump and artificial pancreas for people with diabetes. This technology will allow for miniaturization that will offer people with diabetes a new level of convenience and discretion to manage the disease.

SFC Fluidics, Inc. has a mission to advance healthcare and improve quality of life through our enabling microfluidic technologies. The company’s vision is to become a recognized global leader in the drug delivery and health monitoring markets where our unique product lines improve lifestyle and affordability. SFC Fluidics® is a VIC Technology Venture Development™ portfolio company.

Research reported in this release was supported by The National Institute on Drug Abuse of the National Institutes of Health under grant number [2R44DA041173-02]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Read the full story at http://www.prweb.com/releases/SFCFluidicsDeveloping/ImplantForDrugDelivery/prweb14639592.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Heidelberg Instruments receives orders for advanced VPG+ Volume Pattern Generator from two Asian based photomask suppliers
2. Worcester Polytechnic Institute Receives National Institutes of Health Funding to Develop a Heart Muscle Patch
3. Benchworks Receives Industry Accolades
4. Kibow Biotech Inc. (Buzz of Bio Winner, 2014) Receives US Patent for Gout/Hyperuricemia Product Formulation Based on Modulation of the Gut Microbiome With Probiotics and Prebiotics
5. Heidelberg Instruments receives order for an advanced VPG Large Area Volume Pattern Generator
6. G-CON Manufacturing CEO Receives Recognition as a Top Pharmaceutical Industry Influencer
7. Worcester Polytechnic Institute Receives $1.6 million NIH Award to Study Gender Differences in Neurobiology
8. Singota™ Solutions CEO Receives 2017 Distinguished Alumni Award
9. Prometic Receives $9.5 Million Purchase Order From Multinational Client
10. Intralytix Receives FDA Regulatory Clearance for Phage-Based Shigella Technology
11. Bactana Animal Health Receives Patent Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2019)... ... February 20, 2019 , ... Superior Controls, Inc. , a leading life ... on both the east and west coasts, today announced the recent hiring of Ron ... company’s Seabrook, New Hampshire office. In his new role, Case will use his ...
(Date:2/19/2019)... ... February 19, 2019 , ... VetStem Biopharma ... manufacturing experience. In October 2018, VetStem authorized the formation of Personalized Stem Cells, ... its stem cell patents, data, and FDA filings to launch into human stem cell ...
(Date:2/14/2019)... (PRWEB) , ... February 14, 2019 , ... ... of helium based leak testing systems for the pharmaceutical, biotechnology and food industries, ... company moving forward. Brian Mulhall has been named Chief Executive Officer ...
(Date:2/6/2019)... ... February 05, 2019 , ... Firmex announced today that VERTU ... acquire Firmex, one of the fastest-growing and most widely-used providers of virtual data ... Debt financing was provided by the Bank of Montreal. , Headquartered in Toronto, ...
Breaking Biology Technology:
(Date:2/12/2019)... SASKATOON, Canada (PRWEB) , ... February 12, 2019 ... ... immediately it will begin operating under its new name, KEYLEAF. The company ... more of its own plant-based extracts and ingredients as finished products under the ...
(Date:2/2/2019)... ... January 31, 2019 , ... ... , geared toward clinical operations executives and focusing on all facets of clinical ... effective project management, portfolio management, resource management, patient engagement, and more. , ...
(Date:1/25/2019)... ... January 24, 2019 , ... ... PhD, Assistant Professor of Microbiology at the Jackson Laboratory (JAX), to its Scientific ... world, Dr. Oh will bring to uBiome expertise in skin microbial interactions and ...
Breaking Biology News(10 mins):